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Abst rac t
A wide range of imaging studies provides growing support
for the potential role of diffusion tensor imaging (DTI) in
evaluating microstructural white matter integrity in Alzheimer
disease (AD) and mild cognitive impairment (MCI). Our
review aims to present DTI principles, post-processing and
analysis frameworks and to report the results of particular
studies. 
The distribution of AD-related white matter abnormalities is
widely discussed in the light of deteriorated connectivity with-
in certain tracts due to secondary white matter degeneration;
primary alterations are also assumed to contri bute to the pat-
tern. The question whether it is more effective to assess
the whole-brain diffusion or to directly concentrate on spe-
cific regions remains an interesting issue. Assessing white
matter microstructure alterations, as evaluated by group-lev-
el differences of tensor-derived parameters, may be a promis-
ing neuroimaging tool for differential diagnosis between AD,
MCI and other cognitive disorders, as well as being partic-
ularly helpful in the interpretation of underlying pathologi-
cal processes.
Key words: Alzheimer disease, diffusion tensor imaging, mild
cognitive impairment.
St reszczenie
Rosn¹ca liczba badañ naukowych wskazuje na znaczenie obra-
zowania tensora dyfuzji (DTI) w ocenie mikrostrukturalnej
integralnoœci istoty bia³ej w chorobie Alzheimera (ChA) i ³a -
godnych zaburzeniach poznawczych (£ZP). W niniejszej
pracy przegl¹dowej omówiono zasady obróbki danych oraz
analizy DTI i przedstawiono wyniki poszczególnych badañ
prezentuj¹cych ró¿ne modele charakterystycznych dla ChA
zmian w istocie bia³ej.
Szeroko dyskutowane jest rozmieszczenie uszkodzeñ w isto-
cie bia³ej, g³ównie w odniesieniu do wtórnego zwyrodnienia
poszczególnych w³ókien wskutek zaniku istoty szarej lub pier-
wotnego zwyrodnienia istoty bia³ej. Interesuj¹cy i nieroz-
strzygniêty pozostaje dylemat, czy bardziej efektywne jest
obrazowanie zmian dyfuzji w ca³ym mózgu, czy skupianie siê
na konkretnych strukturach. Zastosowanie DTI w ocenie
mikrostrukturalnych zmian zachodz¹cych w istocie bia³ej
mózgu mo¿e byæ obiecuj¹cym narzêdziem w ró¿nicowaniu
pomiêdzy ChA, £ZP i innymi zaburzeniami poznawczymi;
jest szczególnie przydatne przy interpretacji le¿¹cych u ich
pod³o¿a procesów patologicznych.
S³owa kluczowe: choroba Alzheimera, obrazowanie tensora
dyfuzji, ³agodne zaburzenia poznawcze.
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Introduction
Diffusion-tensor imaging (DTI) is a noninvasive ma -
gnetic resonance imaging (MRI) technique developed
to better characterize the directionally dependent nature
of proton diffusion in cerebral tissue. By taking advan-
tage of the anisotropic nature of water diffusion in tis-
sues [1,2], DTI has become a promising method in
the detection of in vivo microstructural white matter alte -
rations [3-5]. In this approach, variability of diffusion
in each voxel is described by a mathematical model of
diffusion tensor. The diffusion ellipsoid is characterized
by three eigenvectors that represent the orientations
of the main axes and three eigenvalues that represent
the diffusivity along each axis. To calculate the tensor, at
least 6 diffusion-weighted images (acquired by non-
collinear motion probing gradients) and at least one non-
diffusion-weighted image need to be obtained [6].
Basic parameters characterizing
the diffusion tensor
In an isotropic environment (such as a glass of
water), diffusion follows a Gaussian distribution and
exhibits the same behaviour in all directions. When
the random motion of water molecules is directionally
restricted (e.g. inside a cylinder), it is referred to as
anisotropic. The degree of this restriction is often
expressed as fractional anisotropy (FA), which ranges
from zero (for isotropic diffusion) to unity (for diffu-
sion exclusively along one direction). In healthy (well-
organized) white matter tracts water diffuses more freely
along the axonal fibres and FA is expected to be high
[7], while diffusion perpendicular to the fibres is rela-
tively restricted.
As fibres lose integrity due to underlying pathologi-
cal processes that affect axonal density and homogeneity,
changes in the diffusion characteristics of water molecules
are reflected in DTI metrics. DTI has therefore been
applied in the examination of a variety of neurodegene -
rative disorders, in Alzheimer disease (AD) [8-10], mild
cognitive impairment (MCI) [11,12] and age-related
white matter changes [13]. In these studies (and many
others), microstructural white matter alterations were eva l-
uated by means of FA, along with the mean diffusivity
(MD) [5,7]. Moreover, additional scalars may be deriv -
ed from the diffusion tensor, such as axial and radial 
diffusivity, which characterize diffusivities parallel and
perpendicular to white matter tracts, respectively [13,14]
(Fig. 1).
Based on Monte Carlo simulations, it has been re -
ported that at least 30 gradient directions are required
for robust MD calculation [16] and minimally 20 gra-
dient directions for FA [6,9,16]. In practice, the num-
ber of motion-probing gradients used will depend on
the hardware and scan time available. Additionally, a di -
rect comparison of results reported by various authors is
difficult as the signal-to-noise ratio (SNR) is very ra rely
reported and the quality of tensor fit cannot be guessed.
Comparing diffusion parameters
The comparison of DTI results across studies is fur-
ther complicated by the fact that authors have used var-
ious methods of analysis, such as region-of-interest
(ROI) or voxel-wise approaches, with further correc-
tions and additional refinements. The choice of method-
o logy pertaining to image analysis seems to be an impor-
tant factor affecting the results of various DTI studies.
ROI-based analysis
DTI studies on AD and MCI have reported reduc -
ed FA in a variety of white matter areas using a region
Fig. 1. Viewing diffusion tensor imaging data with FSLView (tool from FRMIB
Software Library). The present map is showing the principal direction of dif-
fusion tensor. Red colour corresponds to medio-lateral direction, green to ante-
rior-posterior, and blue- to dorso-ventral orientation. CC – corpus callosum
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of interest-based approach, often combined with man-
ual tracing, masking or tractography to guide ROIs
[17-24]. ROI-based analysis represents the most com-
mon approach in DTI studies, with advantages con-
cerning the statistical analysis of results. Nevertheless,
it has numerous limitations that have been described by
various authors. It is time consuming [25], not easily
reproducible, and not optimal for mapping white mat-
ter abnormalities in the whole brain [11,26]. Further-
more, it is dependent on an a priori hypothesis regard-
ing the regional distribution of white matter alterations,
due to the fact that it is based on examination of vari-
ous tracts [11,27,28]. Therefore, ROI-based analyses
seem to be useful only when the target tract is already
known and anatomically identified [11]. Artefactual 
re sults are related to the shape and size of ROIs, as 
well as the accuracy with which they are placed [8,25,
29,30]. 
Another limitation is that the data obtained by this
method are easily contaminated by unintended fibres
[11]. DTI metrics may also be affected by partial vo -
luming [26] in the proximity of grey matter or cere-
brospinal fluid (CSF). Although the application of
smaller ROIs may reduce partial volume effects, it is ac -
companied by a concomitant decrease in SNR [25,29].
Nevertheless, despite the constantly growing reliability
and accuracy of anatomical information provided by
ROI-based analysis, definitions of anatomical borders
vary across studies [14]. 
Voxel-based analysis
A growing number of studies employ methods of
analysis that circumvent the limitations of an a priori
defined ROI, enabling a more detailed assessment
of microstructural white matter changes. Voxel-based
morphometry (VBM) and tract-based spatial statistics
(TBSS) studies assess white matter differences on a vox-
el-by-voxel basis [14,31]. Among the advantages of
the voxel-based approach is the ability to assess the entire
brain [12,30,32], in contrast to the ROI regional bias.
This advantage, on the other hand, may be considered
a disadvantage in terms of statistical analysis [32]. Vo -
xel-based analysis can circumvent manually introduced
errors (in the manual placement of ROIs) and is a ful-
ly automated method of analysis [12]. Voxel-based mor-
phometry (VBM) was originally developed for the as -
sessment of grey matter changes [33]; modified VBM
analysis can be applied as a voxel-wise investigation
of whole brain anisotropy. Numerous previous AD and
MCI studies, using voxel-by-voxel analysis, have shown
reduced FA in particular brain regions [27,34,35].
However, voxel-based approaches often suffer from low
statistical power due to the fact that information from
each voxel can be highly noisy [32] and can be prob-
lematic in relation to the precise alignment of tract anato-
my [30,36].
In order to conduct comparative examination of
the entire white matter changes between the subjects,
DTI data have to be previously normalized to a tem-
plate space. The normalisation-based approach is often
combined with matching DTI data with atlas-based
anatomical information [32].
Whole brain analysis vs. structure
specific analysis 
Tract-based spatial statistics (TBSS), a part of
FMRIM Software Library (FSL) [36], is another auto-
mated whole-brain analysis technique, which uses vo-
xel-based analysis on tensor-derived data [37]. Once
the TBSS approach was suggested to provide even more
consistent results across subjects than traditional voxel-
based and manual ROI-based ap proaches [37], it has
become a popular method for as sessing white matter
integrity in AD and MCI patients [8,28,39,40]. In this
approach white matter information is condensed to ‘mean
FA skeleton’ [37]. TBSS was created to alleviate mis-
alignment problems and to reduce data contamination
by adjacent structures. Applying sophisticated algorithms
for DTI registration that solve problems related to
the proper alignment of FA images across multiple sub-
jects, it can facilitate subsequent voxelwise analysis.
Another method, structure-specific statistical map-
ping of white matter tracts, is involved in segmentation
of major white matter tracts, fitting them with deformable
geometric medial models and followed with the subse-
quent projection of white matter information to previ-
ously defined white matter tracts [38]. To account for
the connectivity differences, tractography-driven struc-
ture-specific statistical mapping may be even more effec-
tive than that performed on the whole brain [38].
Pathophysiology
Pathological changes in AD include the accumula-
tion of amyloid plaques and neurofibrillary tangles,
along with neuronal loss culminating in gross cerebral
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atrophy. Consistent with previous pathological and
structural MRI studies, these changes originate in
the medial temporal region, including the transento -
rhinal cortex, entorhinal cortex and hippocampus, sub-
sequently spreading over wider temporal and parietal
cortices [41]. Degenerative changes may also lead to
decreased white matter integrity in the cortical associ-
ation areas [30]. 
Overall, DTI studies have shown an inhomogeneous
pattern of white matter abnormalities in AD and MCI
in regions connected with association cortices [8,9,
14,25]. Zarei et al. suggested that the distribution of
degenerative changes is determined, at least partially, by
the connectivity of regions that are anatomically and
functionally linked [42]. 
There is still discussion regarding the pathophysiol-
ogy underlying white matter abnormalities in AD and
MCI. The main issue is whether deteriorated connec-
tivity within certain white matter tracts is due to prima-
ry white matter pathology or secondary, due to perikaryal
degeneration [8,25].
Wallerian degeneration
One theory regarding white matter changes in AD
and MCI patients is that microstructural white matter
changes occur as a result of Wallerian degeneration
[43]. According to this theory, white matter abnormal-
ities follow the pattern of grey matter pathology [41]
and may involve impairments close to the cortical areas
with the greatest pathological burden [44]. DTI met-
rics, reflecting the diffusion characteristics of water in
the tissue, are potentially influenced by increased extra-
cellular fluid following the degeneration of axonal fibres
secondary to neuronal cell loss [20,45]. Correspond-
ingly, Cho et al. noted that atrophy of the callosal body
in AD may occur as a result of Wallerian degeneration
due to cortical lesions, along with the loss of interhemi-
spheric fibres [26]. There is further evidence for dimin-
ished white matter integrity and decreased FA in the
temporal lobe of AD and MCI patients, including
parahippocampal white matter.
Consistently, Huang et al. suggested that perikaryal
degeneration in the cerebral cortex can lead to axonal
loss in the adjacent white matter [9]. Overall, several re-
searchers have supported the hypothesis that neurode-
generation is related to microstructural changes in
the cerebral white matter of subjects with AD and MCI
[4,27,30,46].
Retrogenesis
The alternative retrogenesis theory assumes that di -
minished white matter integrity is the result of myelin
breakdown (that occurs in reverse order to myelogene-
sis), suggesting that white matter degeneration is a direct
consequence of AD pathology [47,48]. It has been hypo -
thesized [30,49] that regions which become myelinated
later in brain development (including neocortical as -
sociation and allocortical fibres) are characterized by
a smaller amount of oligodendrocytes that support
a greater amount of axons in comparison to regions that
become myelinated earlier (including primary sensori-
motor regions). Oligodendrocytes in these regions are
particularly taxed in the metabolic sense, because they
maintain distributed axonal networks. Therefore, axon-
al fibres in cortical association areas are more suscepti-
ble to pathological processes, such as oxidative stress
[30]. According to the retrogenesis model, pathways
with small diameter fibres that myelinate later in normal
development are the first to be affected by the AD dege -
nerative process [47] and pathways with large diameter
fibres that myelinate first in development (such as pri-
mary motor fibres) are the last to be affected by AD
[23]. Consistently with the retrogenesis model, signifi-
cantly lower FA values in AD patients were noted in late-
myelinating corticocortical association fibre pathways
(uncinate fasciculus, inferior longitudinal fasciculus,
superior longitudinal fasciculus), limbic pathways (fornix,
stria terminalis, cingulum) and commissural pathways
(splenium of the corpus callosum) [14,17,23]. In con-
trast, no significant differences in FA were seen in the
early-myelinating pathways: primary motor and sensory
regions, cerebral peduncles, internal capsule, and coro-
na radiata. Overall, the entire sequence is compatible with
the progression of cognitive changes in AD (memory,
language and executive function deficits [23]), with rela -
tive preservation of sensory and motor functions.
Mixed model
Despite numerous contributions to the retrogenesis
theory [25,28,35], there is no clear consensus across
studies in support of one neuropathological mechanism
explaining white matter changes occurring in AD. Many
studies have included remarks distinctive for both mo -
dels [22,34,40,50,51]. Late-myelinating structures (sple -
nium, fornix, stria terminalis and cingulum) connect to
medial temporal lobe structures that are affected early
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in AD, so it is also possible that the observed white mat-
ter changes may reflect Wallerian degeneration secon -
dary to neuronal loss as well [43]. Even though direct
results of many studies are compatible with the retroge-
nesis model, possible contributions from Wallerian
degeneration to white matter changes in AD cannot be
excluded. For instance, it has been hypothesized that
white matter changes are more likely to occur in the infe-
rior longitudinal fasciculus than in the superior longi-
tudinal fasciculus, because the inferior longitudinal fas-
ciculus contains connections between the occipital area
and medial temporal lobe affected earlier in the AD neu-
ropathological process [23]. 
In contrast, the superior longitudinal fasciculus pri-
marily connects the parietal and frontal lobes, which are
affected later in the disease process than medial tempo-
ral lobe structures [23]. Other studies have additional-
ly displayed white matter changes observed in the frontal
association fibres, suggesting that they may occur at
a relatively early stage of the disease process [17,25,50].
Whereas this area is generally considered to be altered
later in AD, evaluation of early changes found in the
frontal white matter may be of benefit in the early diag-
nosis of AD. 
Furthermore, findings concerning the corpus callo-
sum contribute to the retrogenesis theory, since the genu
of the corpus callosum, projecting to the prefrontal cor-
tex, is myelinated later than the splenium [47]. How-
ever, in light of the fact that most authors have report-
ed FA and MD changes in the splenium, a structure
consisting of abundant fibres connecting temporo-pa -
rieto-occipital regions, it could be therefore interpreted
as providing greater support for Wallerian degeneration
than for retrogenesis [14]. 
Vascular changes
Subcortical vascular damage is another important
finding, reflected mainly by white matter hyperintensi-
ties, and is common to aging, MCI, AD, as well as cere-
brovascular disease. Such white matter damage could
also alter white matter integrity through direct injury to
subcortical axonal fibres, which has been particularly
emphasized in studies focusing on the interhemisphe -
ric connections of the corpus callosum [21]. However,
it has been shown that regional patterns of white matter
hyperintensities and alterations in white matter FA are
at least partially distinct for both cerebrovascular disease
and neurodegenerative processes [21].
DTI findings
Since cognitive functions depend on the cooperation
of various brain networks, reduced FA and increased
MD can be observed in widespread brain regions. In
the last decade, a great number of AD and MCI stud-
ies have focused on the following regions: frontal white
matter, temporal white matter, parietal white matter, hip-
pocampus, cingulum (posterior, middle, anterior), cor-
pus callosum (genu, splenium), superior longitudi nal
fasciculus, inferior longitudinal fasciculus, and uncina -
te fasciculus. A large number of studies examining 
white matter integrity, particularly within distributed
temporal networks, have shown differences between AD
patients, MCI subjects and controls in several subcor-
tical regions [8,10,25,30,39]. Huang et al. suggested
that reductions in FA may follow a regional pattern,
reflecting the greatest white matter abnormalities in
the temporal brain regions, followed by changes in the
parietal, then frontal white matter, whereas no signifi-
cant changes are present in the occipital white matter
[9]. Nevertheless, in a meta-analysis conducted by Sex-
ton et al., the authors reported decreased FA in AD
patients in all regions, except for parietal white matter
and the internal capsule [14]. Changes in MCI seem
to generally follow the pattern that differentiates AD
patients from healthy subjects. Subsequently, according
to the same authors, FA values in MCI were lower in
all white matter regions, except for parietal and occipi-
tal white matter.
However, results were more variable (with lower sta-
tistical significance) in the MCI group of patients. In
order to precisely evaluate the disease progression, sev-
eral cross-sectional and longitudinal AD and MCI stud-
ies examined correlations between DTI parameters and
cognitive scores measured by neuropsychological tests.
Most notably, reduced scores in the Mini-Mental State
Examination (MMSE) were significantly associated
with reduced FA [4,10,46] or increased MD [4,27,46]
in the evaluated white matter regions. No significant dif-
ferences in DTI parameters were observed when com-
paring degenerative white matter alterations between
hemispheres in AD and MCI patients [14]. 
Changes in DTI metrics, measured in AD and
MCI subjects, may be observed in both the anterior and
posterior cerebral white matter [10,25,34,50]. Some
studies have reported white matter changes in AD pa -
tients predominantly in anterior regions (e.g. genu of
corpus callosum) [17,25,46,50], whereas others have
reported that white matter changes occur predominantly
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in posterior regions, such as the posterior cingulum and
the posterior corpus callosum [11,20,22,27,30,34,51].
However, because of the inconsistencies across these 
and numerous other studies, the issue of posterior or
anterior predominance in AD still remains open for 
further DTI studies. Further information could possi-
bly provide more insight into the pathophysiological
nature of AD and MCI, as spatial distribution of white
matter changes may reflect a particular kind of patho-
genesis. 
Corpus callosum (genu vs. splenium)
The corpus callosum, as the major white matter net-
work, consists of corticocortical interhemispheric fibres.
Corticocortical disconnections, occurring due to atro-
phy of this highly myelinated structure, correspond to
cognitive impairment [21,26]. Numerous DTI studies
have examined global or regional corpus callosum
changes in AD and MCI patients [10,12,20,21,23, 25,
27,46,50,51]. Most of these studies concentrated dire -
ctly on investigating FA and MD alterations in the genu
and the splenium of the corpus callosum, but not in the
middle corpus callosum (middle and posterior body).
However, there are studies that measured AD-related
FA values in all corpus callosum regions [21]. Lee et al.
hypothesized that both degenerative and cerebrovascu-
lar processes in AD additively affect the anterior corpus
callosum (genu), whereas the main impact of the white
matter degenerative process is prominent essentially in
the posterior corpus callosum (splenium). These results
are also compatible with those of Kavcic et al. It has been
proposed that the selective vulnerability of posterior cere-
bral white matter distinguishes AD patients from healthy
subjects, while anterior and middle white matter integri-
ty may be relevant to cognitive decline in both healthy
and AD subjects, supposedly due to the additional vas-
cular impact [20,21]. In a meta-analysis by Sexton et al.,
it was shown that changes in FA and MD are charac-
teristic for both the splenium and the genu of AD pa -
tients, with the changes in the splenium appearing more
significant [14]. These findings support the theory that
deteriorated integrity of the splenium is closely associat -
ed with secondary degenerative changes of axonal fibres,
corresponding to the Wallerian degeneration model
[14,21]. 
Nevertheless, there are numerous inconsistencies
across publications; a wide range of DTI studies on
the splenium have reported FA/MD changes not only
in patients with established AD [4,25,46,50] but also
in patients with MCI [22,26]. Zhang et al. found sig-
nificantly reduced FA in the splenium of the corpus cal-
losum in AD, but not in MCI [51]. Wang et al. ob -
served decreased FA in the genu of the corpus callosum
in MCI patients [24]. Chen and Lin et al. and Chen
and Chen et al. reported that the genu is involved in both
AD and MCI groups, whereas more prominent white
matter impairment in the splenium of the corpus callo-
sum appears to be related specifically to AD progres-
sion [25,44]. Therefore, assessing changes in the genu
of the corpus callosum may be helpful in distinguish -
ing MCI patients from healthy controls. A further as -
sumption could be made that reduced FA and elevated
MD in the genu and splenium of the corpus callosum
may possibly constitute useful AD markers. However,
our knowledge about regional corpus callosum changes
in AD and MCI remains insufficient [21]. Moreover,
there are numerous discrepancies concerning the con-
version rate from MCI to AD. Subsequently, longitu-
dinal studies are necessary to indicate whether FA and
MD measured in corpus callosum regions are reliable
neuroimaging biomarkers in terms of AD progression
and MCI conversion to AD.
Cingulum (posterior vs. anterior
cingulum)
The idea that DTI measures of abnormalities in
the posterior white matter may be used as indices of dis-
ease progression is further supported by the fact that
the posterior cingulum, contrary to the anterior cingu-
lum, is considered to be an important part of the Papez
circuit [27]. A bundle of white matter fibres, project-
ing from the posterior cingulum to the entorhinal cor-
tex, has been shown to be involved in the cognitive net-
work closely related to memory function. It has been
hypothesized that the integrity of fibres connecting
the medial temporal lobe with the posterior cingulum is
diminished even at an early stage of AD [39,51]. Fur-
ther more, consistently with pathological and neuro -
imaging studies, numerous studies have shown decreas -
ed FA in the posterior cingulum [11,12,40,51], along
with increased MD [27]. Therefore, diffusion tensor-
driven parameters were suggested to be sensitive neu-
roimaging biomarkers of early AD, including preclini-
cal stages of AD. Kiuchi et al. found that FA values in
the bilateral posterior cingulum bundles in MCI sub-
jects were significantly decreased when compared to con-
Diffusion tensor imaging in AD and MCI
Neurologia i Neurochirurgia Polska 2012; 46, 5468
trols; however, no significant differences were demon-
strated between MCI and AD subjects [11]. These
findings may lead to the assumption that alterations in
the posterior cingulum precede the onset of dementia,
indicating DTI changes in this region as a possible
marker of the earliest stages of AD. However, as men-
tioned in the previous section, in order to develop reli-
able markers predicting the conversion of MCI to AD,
longitudinal studies are needed. The MCI group would
be subsequently considered as a diagnostic category
of patients that also potentially includes a number of sub-
jects presenting a preclinical stage of AD [30]. Never-
theless, Cho et al. found significant changes in the pos-
terior cingulum in the AD group, but not the MCI
group [26]. There are various other studies which have
reported contradictory results, finding lower FA in the
anterior portion of the cingulum, along with disease pro-
gression [10]. A possible explanation is the partial effect
of white matter hyperintensities in the anterior region,
related to the prevalence of vascular factors, which may
influence the outcomes [21].
Uncinate fasciculus, superior 
and inferior longitudinal fasciculus
Some studies that focused on assessing differences in
FA and MD across AD, MCI and healthy subjects have
reported additional white matter abnormalities in the
superior longitudinal fasciculus, inferior longitudinal 
fasciculus and uncinate fasciculus [8,11,19,23,26-28,
30,44]. The superior longitudinal fasciculus, connect-
ing frontal and parietal regions, and the inferior longi-
tudinal fasciculus, connecting temporal and occipital
lobes, appear to play an important role in memory, atten-
tion and executive functions. It has been suggested that
the integrity of the superior longitudinal fasciculus and
inferior longitudinal fasciculus may be diminished in
pathological processes such as AD [19,26,44]. Cho et al.
found significant changes in the superior longitudinal
fasciculus and inferior longitudinal fasciculus in AD and
MCI groups compared to healthy volunteers, whereas
no significant changes were observed in other temporal,
parietal, and frontal white matter [26]. This finding may
possibly indicate another biomarker for disease progres-
sion. However, when comparing the inferior longitudi-
nal fasciculus (that interconnects between areas affected
early in AD) with the superior longitudinal fasciculus
(that connects regions affected in advanced AD stages),
significant FA alterations are more expected in the infe-
rior longitudinal fasciculus [23]. 
Diminished integrity of the uncinate fasciculus con-
necting the prefrontal region with the medial temporal
lobe has also been reported in AD [8,11,23,28,30] and
MCI patients [11]. Damoiseaux et al. raised the issue
of the symmetry of white matter degeneration, report-
ing changes in the bilateral uncinate fasciculus when
thresholding mean FA more liberally in TBSS analysis,
although significantly decreased FA was reliably report-
ed only in the left uncinate fasciculus. For this reason,
when discussing possible lateralization of white matter
alterations measured by tensor-derived parameters, it is
important to take into consideration limitations of the
applied methods of analysis [8]. 
Fornix and thalamus
In AD patients, decreased FA and elevated MD
were observed in the fornix, which is an important out-
flow tract of the hippocampus [10,19]. Mielke et al.
found significant differences in fibre integrity for the AD
group, but not for the MCI group [10]. Some further
DTI studies have demonstrated the presence of hip-
pocampal connections directly to the anterior thalamus
via the fornix, and to the pulvinar via the temporopul -
vinar tract [18,42]. These connections seem to play an
essential role in impaired episodic memory in AD pa -
tients [52]. The greatest reduction in intra-thalamic FA
was noted in the dorsal anterior region of the thalamus
[8,42] along with white matter abnormalities found in
the proximity of the hippocampal formation. These
results signify AD-related decreased fibre integrity of
the normally abundant connections between the medial
temporal lobe and the thalamus. These outcomes are
consistent with previous DTI studies on disrupted con-
nectivity in the pathways leading to the hippocampus
[8,10,18,22,34,51].
Unaffected regions
In evaluation of DTI metrics, unaffected white mat-
ter regions seem to play an important role. These regions
may be used as an internal reference in differentiating
between altered and healthy regions. For this purpose,
studies have indicated the following bundles of fibres:
corticospinal tract [11] and occipital white matter [9].
Other DTI reports have not reported any significant
difference between AD and control subjects in early
myelinating areas, such as the cerebral peduncles and
the posterior limb of the internal capsule [23,40,50,51],
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providing support for the retrogenesis pathogenetic
models.
Age-related studies
The pattern of degenerative processes occurring in
brain white matter has been widely examined in both
AD and MCI, and also in aging subjects [8,24,53-57].
The majority of these age-related studies in the healthy
population have reported decreased FA predominantly
in the frontal white matter and the anterior corpus cal-
losum. In particular studies, diminished white matter
integrity was found within parietal regions [8,53,58],
whereas according to other reports, parietal and tempo-
ral white matter is spared in healthy elderly subjects
[55,56]. Head et al. hypothesized that age-associated
abnormalities are exhibited more anteriorly in compar-
ison with changes characteristic for AD. Overall, a dif-
ferent pattern of diffusivity changes in normal aging and
AD patients is compatible with the statement that AD
is not a simple acceleration of aging [8]. 
Discussion
A wide range of imaging studies provides growing
support for the potential role of diffusion tensor imag-
ing (DTI) in evaluating AD-related neurodegenerative
processes in the brain. Whereas brain atrophy, which is
the most characteristic imaging hallmark of AD, can be
evaluated on different structural levels (including global
brain volume reduction, localised grey matter atrophy
and subcortical atrophy), evaluating diffusion data can
bring valuable information of microstructural white mat-
ter integrity.
In practice, a DTI sequence can be easily included
in the standard MRI protocol, along with the conven-
tional structural (T1-weighted) sequence. In the last two
decades, a wide range of optimised, robust algorithms
for DTI analysis has been developed, focusing particu-
larly on solving problems in terms of spatial alignment
and computation of diffusion data, enabling subsequent
voxel-based or ROI-wise analysis. However, a direct
comparison between different approaches is complicat-
ed due to the bias in diffusion data introduced by dif-
ferent acquisition and post-processing steps. The ques-
tion whether it is more effective to assess the whole brain
diffusion or to directly concentrate on specific structures
and regions remains a substantial issue that is still open
to debate. Nevertheless, it is worth noting that several
methods of analysis can be possibly applied within one
study, so voxel-based analysis results can be compared
with those of region-of-interest or tract-specific analysis.
The pattern and extent of white matter changes in
AD and MCI are still under debate, regarding the
underlying pathophysiology. The distribution of white
matter abnormalities is widely discussed mainly in
the light of deteriorated connectivity within certain tracts
due to secondary degeneration occurring as a result
of grey matter atrophy; however, the contribution of pri-
mary white matter degeneration to the general pattern
cannot be excluded.
White matter microstructure changes, as evaluated
by group level differences of tensor-derived parameters
(FA, MD, axial and perpendicular diffusivity), can rep-
resent a promising neuroimaging biomarker in the diag-
nosis of AD. Whereas cross-sectional DTI studies have
brought more insight into our understanding of the
pathogenesis of AD when compared with healthy con-
trols, further longitudinal studies are needed to assess
the role of DTI in monitoring of disease progression
and the conversion of MCI to AD. 
Furthermore, due to the relatively complex clinical
evaluation of neurodegenerative disorders, a noninva-
sive DTI approach may be a promising tool for differ-
ential diagnosis between various dementias, and micro -
structural white matter integrity assessment can shed
more light on interpretation of different underlying
pathological processes. 
Summary
The aim of our review was to show the potential role
of DTI as a powerful tool in evaluating microstructu ral
white matter integrity in Alzheimer’s disease. The DTI
processing and variability analysis framework has been
briefly described and the results of particular DTI stud-
ies presented, showing different patterns of AD-related
white matter alterations. Assessing white matter micro -
structure alterations, as evaluated by group level differ-
ences of tensor-derived parameters, may be a promising
neuroimaging tool for differential diagnosis between
AD, MCI and other cognitive disorders, as well as being
particularly helpful in the interpretation of underlying
pathological processes.
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